1. Ozlu T, Bulbul Y, Alatas F, et al. Consensus report on diagnosis and treatment of community-acquired pneumonia in adults. Tuberk Toraks. 2009;57(2):119-147.
2. Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection. 2004;32(4):234-238. doi:10. 1007/s15010-004-3107-z
3. Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15(4):757-763. doi:10.1034/j.1399-3003.2000.15d21.x
4. Cemek M, Caksen H, Bayiroğlu F, Cemek F, Dede S. Oxidative stress and enzymic-non-enzymic antioxidant responses in children with acute pneumonia. Cell Biochem Funct. 2006;24(3):269-273. doi:10.1002/cbf.1220
5. Celebi OO, Diker E, Aydogdu S. Clinical importance of cardiac troponins. Turk Kardiyol Dern Ars. 2008;36(4):269-277.
6. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. doi:10.1016/j.clinbiochem. 2014.09.026
7. Parlak ES, Alisik M, Karalezli A, et al. Are the thiol/disulfide redox status and HDL cholesterol levels associated with pulmonary embolism?: thiol/disulfide redox status in pulmonary embolism. Clin Biochem. 2017;50(18):1020-1024. doi:10.1016/j.clinbiochem.2017.07.018
8. Parlak ES, Alisik M, Hezer H, Karalezli A, Hasanoglu HC, Erel O. Evaluation of dynamic thiol/disulfide redox state in community-acquired pneumonia. Saudi Med J. 2018;39(5):495-499. doi:10.15537/smj.2018.5.22111
9. Babaoglu E, Kilic H, Hezer H, et al. Comparison of thiol/disulphide homeostasis parameters in patients with COPD, asthma and ACOS. Eur Rev Med Pharmacol Sci. 2016;20(8):1537-1543.
10. Wudkowska A, Goch J, Goch A. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Kardiol Pol. 2010;68(4):431-437.
11. Aran T, Unsal MA, Guven S, Kart C, Cetin EC, Alver A. Carbon dioxide pneumoperitoneum induces systemic oxidative stress: a clinical study. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):80-83. doi:10.1016/j.ejogrb.2011.11.027
12. Ma SG, Wei CL, Hong B, Yu WN. Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 2011;66(10):1677-1680. doi:10.1590/s1807-59322011001000003
13. Lippi G, Montagnana M. Ischemia-modified albumin in ischemic disorders. Ann Thorac Cardiovasc Surg. 2009;15(2):137.
14. Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS. Elevated cardiac troponin T levels in critically ill patients with sepsis. Am J Med. 2013; 126(12):1114-1121. doi:10.1016/j.amjmed.2013.06.029
15. Jaffe AS, Ravkilde J, Roberts R, et al. It’s time for a change to a troponin standard. Circulation. 2000;102(11):1216-1220. doi:10.1161/01.cir.102. 11.1216
16. Pollack ML. ECG manifestations of selected extracardiac diseases. Emerg Med Clin North Am. 2006;24(1):133-143. doi:10.1016/j.emc.2005. 08.009
17. Rubio-Tapia A, García-Leiva J, Asensio-Lafuente E, Robles-Díaz G, Vargas-Vorácková F. Electrocardiographic abnormalities in patients with acute pancreatitis. J Clin Gastroenterol. 2005;39(9):815-818. doi:10. 1097/01.mcg.0000177241.74838.57
18. Frencken JF, Donker DW, Spitoni C, et al. Myocardial injury in patients with sepsis and its association with long-term outcome. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004040. doi:10.1161/CIRCOUTCOMES. 117.004040
19. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi:10.1016/j.jacc.2018.08.1038
20. Upadhyay S, Niederman MS. Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia? Infect Dis Clin North Am. 2013;27(1): 19-31. doi:10.1016/j.idc.2012.11.003
21. Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J. 2011; 37(2):384-392. doi:10.1183/09031936.00035610
22. Kundi H, Ates I, Kiziltunc E, et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-1571. doi:10.1016/j.ajem.2015.06.016
23. Şener A, Kurtoğlu Çelik G, Özhasenekler A, et al. Evaluation of dynamic thiol/disulfide homeostasis in adult patients with community-acquired pneumonia. Hong Kong J Emerg Med. 2019;26(6):343-350. doi: 10.1177/1024907918802956
24. Temel MT, Demiryürek S, Temel L, et al. Dynamic thiol/disulfide homeostasis in children with community-acquired pneumonia. Pediatr Int. 2019;61(3):252-257. doi:10.1111/ped.13773
25. Bolatkale M, Duger M, Ülfer G, et al. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin. Am J Emerg Med. 2017;35(8):1121-1125. doi:10.1016/j.ajem.2017.03.018
1. Ozlu T, Bulbul Y, Alatas F, et al. Consensus report on diagnosis and treatment of community-acquired pneumonia in adults. Tuberk Toraks. 2009;57(2):119-147.
2. Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection. 2004;32(4):234-238. doi:10. 1007/s15010-004-3107-z
3. Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15(4):757-763. doi:10.1034/j.1399-3003.2000.15d21.x
4. Cemek M, Caksen H, Bayiroğlu F, Cemek F, Dede S. Oxidative stress and enzymic-non-enzymic antioxidant responses in children with acute pneumonia. Cell Biochem Funct. 2006;24(3):269-273. doi:10.1002/cbf.1220
5. Celebi OO, Diker E, Aydogdu S. Clinical importance of cardiac troponins. Turk Kardiyol Dern Ars. 2008;36(4):269-277.
6. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. doi:10.1016/j.clinbiochem. 2014.09.026
7. Parlak ES, Alisik M, Karalezli A, et al. Are the thiol/disulfide redox status and HDL cholesterol levels associated with pulmonary embolism?: thiol/disulfide redox status in pulmonary embolism. Clin Biochem. 2017;50(18):1020-1024. doi:10.1016/j.clinbiochem.2017.07.018
8. Parlak ES, Alisik M, Hezer H, Karalezli A, Hasanoglu HC, Erel O. Evaluation of dynamic thiol/disulfide redox state in community-acquired pneumonia. Saudi Med J. 2018;39(5):495-499. doi:10.15537/smj.2018.5.22111
9. Babaoglu E, Kilic H, Hezer H, et al. Comparison of thiol/disulphide homeostasis parameters in patients with COPD, asthma and ACOS. Eur Rev Med Pharmacol Sci. 2016;20(8):1537-1543.
10. Wudkowska A, Goch J, Goch A. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Kardiol Pol. 2010;68(4):431-437.
11. Aran T, Unsal MA, Guven S, Kart C, Cetin EC, Alver A. Carbon dioxide pneumoperitoneum induces systemic oxidative stress: a clinical study. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):80-83. doi:10.1016/j.ejogrb.2011.11.027
12. Ma SG, Wei CL, Hong B, Yu WN. Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 2011;66(10):1677-1680. doi:10.1590/s1807-59322011001000003
13. Lippi G, Montagnana M. Ischemia-modified albumin in ischemic disorders. Ann Thorac Cardiovasc Surg. 2009;15(2):137.
14. Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS. Elevated cardiac troponin T levels in critically ill patients with sepsis. Am J Med. 2013; 126(12):1114-1121. doi:10.1016/j.amjmed.2013.06.029
15. Jaffe AS, Ravkilde J, Roberts R, et al. It’s time for a change to a troponin standard. Circulation. 2000;102(11):1216-1220. doi:10.1161/01.cir.102. 11.1216
16. Pollack ML. ECG manifestations of selected extracardiac diseases. Emerg Med Clin North Am. 2006;24(1):133-143. doi:10.1016/j.emc.2005. 08.009
17. Rubio-Tapia A, García-Leiva J, Asensio-Lafuente E, Robles-Díaz G, Vargas-Vorácková F. Electrocardiographic abnormalities in patients with acute pancreatitis. J Clin Gastroenterol. 2005;39(9):815-818. doi:10. 1097/01.mcg.0000177241.74838.57
18. Frencken JF, Donker DW, Spitoni C, et al. Myocardial injury in patients with sepsis and its association with long-term outcome. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004040. doi:10.1161/CIRCOUTCOMES. 117.004040
19. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi:10.1016/j.jacc.2018.08.1038
20. Upadhyay S, Niederman MS. Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia? Infect Dis Clin North Am. 2013;27(1): 19-31. doi:10.1016/j.idc.2012.11.003
21. Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J. 2011; 37(2):384-392. doi:10.1183/09031936.00035610
22. Kundi H, Ates I, Kiziltunc E, et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-1571. doi:10.1016/j.ajem.2015.06.016
23. Şener A, Kurtoğlu Çelik G, Özhasenekler A, et al. Evaluation of dynamic thiol/disulfide homeostasis in adult patients with community-acquired pneumonia. Hong Kong J Emerg Med. 2019;26(6):343-350. doi: 10.1177/1024907918802956
24. Temel MT, Demiryürek S, Temel L, et al. Dynamic thiol/disulfide homeostasis in children with community-acquired pneumonia. Pediatr Int. 2019;61(3):252-257. doi:10.1111/ped.13773
25. Bolatkale M, Duger M, Ülfer G, et al. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin. Am J Emerg Med. 2017;35(8):1121-1125. doi:10.1016/j.ajem.2017.03.018